תפריט כתבה
Moderna stock surges as melanoma vaccine trial shows "landmark moment"
CBS
17:59, עידכון: 19:57
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.